43,873 Shares in Oscar Health, Inc. (NYSE:OSCR) Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 43,873 shares of the company's stock, valued at approximately $590,000.

Several other hedge funds and other institutional investors have also modified their holdings of OSCR. Tower Research Capital LLC TRC grew its stake in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after purchasing an additional 4,185 shares in the last quarter. KBC Group NV lifted its holdings in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Oscar Health in the 4th quarter valued at approximately $138,000. Virtu Financial LLC acquired a new position in Oscar Health in the fourth quarter worth approximately $140,000. Finally, Potentia Wealth acquired a new position in Oscar Health in the fourth quarter worth approximately $141,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

OSCR traded down $0.10 on Thursday, hitting $13.80. The company had a trading volume of 6,339,473 shares, compared to its average volume of 4,369,730. The stock has a market cap of $3.46 billion, a price-to-earnings ratio of -689.41 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company's fifty day moving average price is $13.74 and its 200 day moving average price is $14.59. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Oscar Health's revenue for the quarter was up 42.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.62 earnings per share. Equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have issued reports on OSCR. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research note on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $20.08.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 24.39% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.